Uranium Energy: Canaccord Lifts Rating To Speculative Buy

Last Monday, Uranium Energy Corp (NYSE: UEC) announced that they would be acquiring UEX Corporation (TSX: UEX) to create “the largest diversified North American focused uranium company.” Uranium Energy will be buying UEX via an all-share transaction, where UEX shareholders will receive 0.0831 shares of Uranium Energy Corp for each share owned.

This implied a per-share consideration of C$0.43 per UEX share and roughly a 50% premium based on the closing price of UEX at the time of signing, which equates to roughly a 14% dilution for existing Uranium Energy shareholders.

Uranium Energy says that this will be an accretive acquisition, as it will double their pro-forma uranium mining claims and will have “the largest uranium portfolio focused exclusively in the Americas, located in proven and stable jurisdictions, and combining diversified U.S. production and Canadian development assets.”

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

UEX has 29 uranium projects which include locations on both the east and west sides of the Athabasca Basin. They also note that 5 out of the 29 projects are in the advanced resource stage, and are “already in strong joint-venture partnerships with established uranium miners.”

Uranium Energy Corp currently has 5 analysts covering the stock with an average 12-month price target of US$6.40, or an upside of almost 90%. Out of the 5 analysts, 2 have strong buy ratings and the other 3 analysts have buy ratings. The street high price target sits at US$7.20 or an upside of about 115%.

In Canaccord’s note on the merger, they reiterate their price target of US$5.50 and upgrade their rating from hold to speculative buy on Uranium Energy Corp, saying that they believe this deal to be a positive for the company but have some potential negative takeaways they shared.

Canaccord believes that most investors will be able to look forward, beyond the 13.7% dilution, to see that there is “good long-term value” that could come out of this deal, especially if the uranium market fundamentals continue to improve.

On the positives, Canaccord believes that with the deal more than doubling their uranium resources in politically stable countries and having pro-forma ownership of roughly 316mlbs of U3O8, it will be positioned properly for a potential switch by utilities to North American assets.

They also note that on an EV/lb basis, Uranium currently trades at US$6.25 a pound whereas UEX trades only at $0.81, suggesting that on this alone, the deal should be accretive to Uranium Energy.

On some of the potential negative things that could arise, Canaccord believes the biggest thing is the upfront dilution to existing Uranium Energy shareholders.

While they also believe that the management of Uranium Energy has “accumulated a very large portfolio over the last 12 months” which could lead to some issues stemming from such a large rollup. They believe that management might have multiple competing priorities they will need to address, but Canaccord tells shareholders that Uranium Energy should and will be “keenly focused on locking in long-term contracts to advance its near-term US assets into production.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

Homeland Nickel Signs Binding Offtake With Westwin for 20,000 Tonnes of Concentrate a Year

Golden Cariboo’s First Quesnelle Resource Estimate Tallies 1.19 Million Gold Equivalent Ounces

Related News

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

Canopy Growth: Analysts Anticipate Q1 Revenues Of $149 Million

Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) announced that they will be reporting their fiscal...

Tuesday, August 3, 2021, 03:28:00 PM

Trulieve Cannabis: Analyst Q1 Consensus Estimates

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their first quarter financials before...

Wednesday, May 12, 2021, 04:01:00 PM

Canaccord Smacks Canopy Growth With $12 Price Target

On November 5th, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their fiscal second quarter...

Monday, November 8, 2021, 10:14:00 AM

Tilray: Haywood Reiterates Hold Rating, $16.50 Price Target

With the Aphria, Tilray (NASDAQ: TLRY) merger finalized and Aphria shares consolidated earlier this month,...

Wednesday, May 19, 2021, 03:38:00 PM